Tissue Repair Ltd
Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. The company utilizes Glucoprime technology, an immunogenic active pharmaceutical ingredient that activates macrophages and stimulates immune response for wound healing and skin regeneration. It develops TR-987, a topical … Read more
Tissue Repair Ltd (TRP) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.091x
Based on the latest financial reports, Tissue Repair Ltd (TRP) has a cash flow conversion efficiency ratio of -0.091x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.26 Million) by net assets (AU$13.91 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tissue Repair Ltd - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Tissue Repair Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Tissue Repair Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tissue Repair Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hiper Global Ltd
TA:HIPR
|
0.127x |
|
TEMPUS RESOURCES LTD
F:4W0
|
N/A |
|
Carmat
PA:ALCAR
|
0.344x |
|
BioNexus Gene Lab Corp Common stock
NASDAQ:BGLC
|
-0.181x |
|
Master Pack Group Bhd
KLSE:7029
|
0.097x |
|
SSH Group Ltd
AU:SSH
|
0.196x |
|
Vyome Holdings, Inc.
NASDAQ:HIND
|
1.108x |
|
IQ-AI Limited
PINK:IQAIF
|
-0.135x |
Annual Cash Flow Conversion Efficiency for Tissue Repair Ltd (2020–2025)
The table below shows the annual cash flow conversion efficiency of Tissue Repair Ltd from 2020 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$13.91 Million | AU$-3.70 Million | -0.266x | +3.12% |
| 2024-06-30 | AU$18.04 Million | AU$-4.95 Million | -0.274x | -41.14% |
| 2023-06-30 | AU$21.88 Million | AU$-4.26 Million | -0.194x | -24.24% |
| 2022-06-30 | AU$25.34 Million | AU$-3.97 Million | -0.157x | -396.87% |
| 2021-06-30 | AU$27.07 Million | AU$-852.89K | -0.032x | +95.15% |
| 2020-06-30 | AU$999.90K | AU$-649.98K | -0.650x | -- |